Chagas disease, caused by the parasite Trypanosoma cruzi, affects 8 million people and imposes a major economic burden due to early mortality and physical disabilities. It is endemic in Latin America but cases are increasing in non-endemic countries, becoming a global concern. Disease progression, from symptomless to severe, are linked to parasite heterogeneity and variable host immune response. Indeed, development of robust CD8+ T cell immunity is a key element of host resistance and T. cruzi persistence and chronic Chagas disease has been associated to suboptimal CD8+ T cell responses. Consequently, defining the nature of CD8+ T cells mediating immunoprotection and the rules governing the maintenance of these cells is crucial for our understanding of the pathogenesis of Chagas disease and also for the design of novel therapeutic and vaccination approaches. Cytokines are central environmental cues that dictate the magnitude and quality of protective CD8+ T cell responses and, thus, emerge as attractive targets for immunointervention. However, our incomplete knowledge about the cytokines, signaling pathways and transcriptional programs involved in the generation of optimal CD8+ T cell immunity holds back possible applications of relevance to human health. Our compelling preliminary findings show that IL-17RA-signaling cytokines are critically involved in the regulation of the developmental pathways that determine the generation of robust protective CD8+ T cell responses to T. cruzi. Using phenotypic, functional and genomic profiling we propose to dissect the mechanisms underlying IL-17RA-mediated regulation of specific CD8+ T cell development. Adoptive transfer experiments together with in vitro culture approaches will be used to establish whether IL-17RA-signaling plays CD8+ T cell intrinsic and/or extrinsic roles in supporting CD8+ T cell immunity. Finally, genetic vaccination and cytokine-based treatment will help to determine the potential therapeutic use of IL-17A to boost CD8+ T cell immunity to T. cruzi during natural infection and vaccination. Our studies will provide meaningful data about the role of IL-17RA-signaling cytokines in the regulation of CD8+ T cell immunity to T. cruzi, providing potential new targets for the rational design of therapies for Chagas disease and, likely, other chronic infections. We also expect to identify the cellular and molecular programs triggered by IL-17RA-signaling and how they dictate particular CD8+ T cell fates. This knowledge will profoundly impact on fundamental immunology and may provide a rationale for understanding unsuspected effects of IL-17-targeted therapies during human diseases.
CD8+ T cells are key elements in the defense against intracellular pathogens and consequently, understanding the signals and pathways that mediate CD8+ T cell development during infections has important implications for vaccine and therapy design. This project will provide mechanistic insights about the roles of IL-17RA- signaling cytokines in the development of robust protective CD8+ T cell immunity to T. cruzi, the parasite that causes Chagas disease. This knowledge will improve our understanding about CD8+T cell developmental pathways and could provide new targets for the rational design of new therapeutic treatments aimed at enhancing protective CD8+ T cell responses during Chagas disease and other chronic infections.
|Tosello Boari, Jimena; Araujo Furlan, Cintia L; Fiocca Vernengo, Facundo et al. (2018) IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Trypanosoma cruzi Infection. Front Immunol 9:2347|
|Onofrio, Luisina I; Zacca, Estefania R; Ferrero, Paola et al. (2018) Inhibitory Receptor Expression on T Cells as a Marker of Disease Activity and Target to Regulate Effector Cellular Responses in Rheumatoid Arthritis. Arthritis Rheumatol 70:1429-1439|
|Araujo Furlan, Cintia L; Tosello Boari, Jimena; Rodriguez, Constanza et al. (2018) Limited Foxp3+ Regulatory T Cells Response During Acute Trypanosoma cruzi Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8+ T Cell Immunity. Front Immunol 9:2555|
|Tosello Boari, Jimena; Acosta Rodriguez, Eva V (2016) IL-1?/CD14 pathway induces IL-17 production: Dendritic cells activated with IL-1? set Th17 cells on fire by CD14-mediated mechanisms. Immunol Cell Biol 94:903-904|